Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

Search & Filter

Enter one or more words in to the search box and press Enter.
With each additional filter selection requires the articles to have each of the categories selected.

  • Filter by Section

  • Filter by Author

NICE recommends Xiapex for treatment of Dupuytren’s disease

April 28, 2023
Rob Mair
People in England with the disabling hand condition Dupuytren's disease will have access to Xiapex (collagenase clostridium histolyticum (CCH)) injections for contracture of their fingers, Swedish Orphan Biovitrum Ltd (Sobi) has announced. 

Number of British smokers down by nearly 2 million since smoking ban

October 7, 2022
admin
The number of British people smoking has fallen by 1.9 million since the introduction of the smoking ban, new figures from Cancer Research UK have revealed. Smoking rates are now the lowest ever recorded.

Greater access to genetic testing needed for cancer diagnosis and treatment

October 6, 2022
admin
Cancer patients should have routine access to genetic testing to improve diagnosis and treatment, according to England's chief medical officer.

NHS needs more advanced paramedics to ease A & E pressure, says NICE

October 6, 2022
admin
NICE is recommending the NHS provides more advanced paramedic practitioners (APPs) to relieve pressure on emergency departments, in new draft guidance.

DEVOTE trial: long-acting insulin results

October 6, 2022
admin
Results of the DEVOTE trial investigating the cardiovascular (CV) safety profile of long-acting insulin, insulin degludec (Tresiba), in adults with type 2 diabetes were presented at the ADA congress.

Long-acting oral insulin tablet provides comparable glycaemic control to insulin glargine injection

October 6, 2022
admin
A long-acting, oral insulin tablet has been found to safely improve glycaemic control as effectively as the common, injected insulin glargine in people with type 2 diabetes according to a study presented at the ADA.

Sex-specific cardiovascular drug dosages are needed to reduce adverse reactions in women

October 6, 2022
admin
Sex-specific cardiovascular drug dosages are needed to reduce adverse reactions in women, according to a position paper from the European Society of Cardiology published in the European Heart Journal €“ Cardiovascular Pharmacotherapy.

Severe obesity in high-risk youth correlates directly to increased incidence of type 2 diabetes

October 6, 2022
admin
The risk of developing type 2 diabetes by age 20 was 12 times as high in severely obese American Indian children aged five to nine years as in normal- weight youth in that age range, according to a study presented at the ADA congress.

SGLT2 inhibitors are associated with lower rates of death for patients with type 2 diabetes

October 6, 2022
admin
A new class of medication, known as sodium- glucose transporter-2 (SGLT2) inhibitors, is associated with lower rates of death and hospitalisation for heart failure when used to treat patients with type 2 diabetes according to a study presented at the ADA conference.

New LEADER trial analysis shows reduction in cardiovascular risk in people with type 2 diabetes

October 6, 2022
admin
New findings from a post-hoc analysis of the LEADER cardiovascular (CV) outcomes trial were presented recently at the 77th annual Scientific Sessions of the American Diabetes Association (ADA).

More than a quarter of women missing smear tests are unaware they exist

October 6, 2022
admin
More than a quarter of women who are overdue for a smear test don't know about the cervical screening programme, according to a Cancer Research UK survey published in the July Edition of the European Journal of Cancer.

New guidance on Primary Sjögren’s Syndrome from the British Society of Rheumatology

October 6, 2022
admin
The first UK guideline on the care of adults with Primary Sjögren's Syndrome has been published by the British Society of Rheumatology and has been accredited by NICE.

Deprivation of liberty safeguards (DoLS): a summary and update

October 6, 2022
admin
Deprivation of Liberty Safeguards (DoLS) were introduced to fill an important gap in legislation in protecting those without capacity whose liberty is restricted. They provide authority to restrict movement or detain individuals, but only if necessary in their best interests to prevent them from harm.

Novel approaches to diet and exercise in obesity and type 2 diabetes

April 12, 2024
James E Brown
There is still a lack of effective obesity treatment options available and current diet and exercise regimes are often unsuccessful for the majority. There is also a paucity of licensed pharmaceutical options available for clinicians to treat obesity with, although new weight loss drugs are emerging.

Alzheimer’s Scotland launches third National Dementia Strategy

October 6, 2022
admin
Alzheimer's Scotland has launched the third National Dementia Strategy for Scotland.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy